By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Biohaven Pharma 

234 Church Street

New Haven  Connecticut  06510  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS



Key Statistics


Email:
Ownership: Public

Web Site: Biohaven
Employees:
Symbol: BHVN
 



Industry
Pharmaceutical






Company News
Biohaven (BHVN) Enrolls First Patient In Pivotal Phase III Clinical Trial Of Oral Rimegepant For The Acute Treatment Of Migraine 7/24/2017 6:21:23 AM
Biohaven (BHVN) Receives Notice Of Allowance From U.S. Patent And Trademark Office On Patent Application For Glutamate Modulating Prodrugs 7/13/2017 6:44:18 AM
Biohaven (BHVN)'s BHV-5000 Receives Orphan Drug Designation From The FDA In Rett Syndrome 7/6/2017 6:58:03 AM
Biohaven (BHVN) Added to Russell Microcap Index 6/26/2017 7:48:13 AM
Biohaven (BHVN) Broadens Senior Leadership Team With Veteran Pharma Executives 6/22/2017 8:55:21 AM
Biohaven (BHVN) Reports First Quarter 2017 Financial and Business Results 6/16/2017 7:18:09 AM
Biohaven (BHVN) Completes Enrollment In Spinocerebellar Ataxia Clinical Trial With Trigriluzole 5/30/2017 8:11:24 AM
Biohaven (BHVN) Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 5/15/2017 6:56:00 AM
Biohaven (BHVN)'s Trigriluzole Receives Fast Track Designation From U.S. FDA 5/15/2017 6:34:31 AM
Biohaven (BHVN) Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 5/12/2017 7:55:52 AM
123
//-->